EPGNY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 Sep 2022 @ 14:34):

Stats
Today's Volume	212.00
Average Volume	9.00
Market Cap	0.00
Last Dividend	$0.0297 ( 2021-09-16 )
Next Dividend	$0 ( N/A )
P/E	-1.604
ATR14	$0 (0.00%)

Epigenomics AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Epigenomics AG Financials

Annual	2021
Revenue:	$6.20M
Gross Profit:	$6.07M (97.81 %)
EPS:	$-0.271

Q3	2022
Revenue:	$145 000
Gross Profit:	$109 000 (75.17 %)
EPS:	$-0.120

Q2	2022
Revenue:	$126 000
Gross Profit:	$95 000.00 (75.40 %)
EPS:	$-0.100

Q1	2022
Revenue:	$115 000
Gross Profit:	$89 000.00 (77.39 %)
EPS:	$-0.210

Financial Reports:

No articles found.

Epigenomics AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Epigenomics AG Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.458 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.833	2018-10-31
Last Dividend	$0.0297	2021-09-16
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	$2.72	--
Avg. Dividend % Per Year	0.00%	--
Score	0.55	--
Div. Sustainability Score	0.458
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-09-23)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

0.55

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
THLLY	Ex Dividend Knight	2023-05-19	Semi-Annually	0.00%
IDKOF	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
BGAOY	Ex Dividend Knight	2023-04-26	Semi-Annually	0.00%
PLDGP	Ex Dividend Knight	2023-09-15	Quarterly	0.00%
EKTAY	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%
UEPCO	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
KCLI	Ex Dividend Knight	2023-08-02	Quarterly	0.00%
CCFC	Ex Dividend Junior	2023-05-12	Quarterly	0.00%
RWEOY	Ex Dividend Junior	2023-05-05	Sporadic	0.00%
FMBN	Ex Dividend Junior	2023-06-05	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.391	1.500	-7.83	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.0984	1.200	-3.28	-3.94	[0 - 0.3]
returnOnEquityTTM	-0.187	1.500	-3.19	-4.78	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	11.06	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	10.72	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	10.72	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0187	-1.500	9.69	-10.00	[0 - 0.6]
interestCoverageTTM	-45.35	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
freeCashFlowPerShareTTM	-0.467	2.00	-0.233	-0.467	[0 - 20]
debtEquityRatioTTM	0.0208	-1.500	9.92	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.978	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.380	1.000	-9.60	-9.60	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-9.03	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.252	0.800	-1.657	-1.325	[0.5 - 2]
Total Score				0.458

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-8.24	1.000	-0.934	0	[1 - 100]
returnOnEquityTTM	-0.187	2.50	-2.05	-4.78	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.467	2.00	-0.156	-0.467	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.463	2.00	-0.154	-0.309	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.463	1.500	-6.42	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.669	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.63

Epigenomics AG

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.